WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 16.96%1.33B | 16.30%993.65M | 19.57%651.71M | 11.16%297.94M | -4.03%1.14B | -7.85%854.42M | -14.17%545.02M | -12.44%268.03M | 7.16%1.18B | 15.63%927.23M |
Operating revenue | 16.96%1.33B | 16.30%993.65M | 19.57%651.71M | 11.16%297.94M | -4.03%1.14B | -7.85%854.42M | -14.17%545.02M | -12.44%268.03M | 7.16%1.18B | 15.63%927.23M |
Other operating revenue | -30.47%1.29M | ---- | -69.59%600.58K | ---- | -82.46%1.85M | ---- | 16.42%1.98M | ---- | -36.27%10.57M | ---- |
Total operating cost | 16.75%1.22B | 17.31%916.99M | 20.96%605.75M | 10.91%279.48M | -3.19%1.04B | -6.82%781.65M | -13.10%500.79M | -9.94%251.99M | 7.49%1.08B | 16.63%838.89M |
Operating cost | 18.63%994.57M | 20.07%752.58M | 24.44%499.7M | 14.92%229.28M | -7.85%838.41M | -12.59%626.78M | -18.85%401.55M | -17.15%199.52M | 6.36%909.8M | 14.83%717.08M |
Operating tax surcharges | 9.19%7.89M | 6.83%6.03M | 13.22%3.95M | 24.54%1.83M | 12.88%7.23M | 18.58%5.64M | 19.08%3.48M | 7.85%1.47M | 24.54%6.4M | 31.46%4.76M |
Operating expense | 14.96%95.08M | 19.17%68.83M | 27.37%44.35M | 25.82%20.95M | 30.52%82.71M | 23.79%57.76M | 13.70%34.82M | 25.56%16.65M | 6.82%63.37M | 34.42%46.66M |
Administration expense | 0.15%55.43M | -4.12%42.01M | -3.31%27.9M | -10.53%13.8M | 7.46%55.35M | 11.89%43.82M | 6.93%28.86M | 19.15%15.43M | 20.13%51.5M | 31.35%39.16M |
Financial expense | -16.54%5.88M | 19.77%5.38M | -1.64%2.36M | -55.59%1.89M | 819.57%7.04M | 187.38%4.49M | 182.49%2.4M | 544.50%4.25M | -137.90%-978.97K | -584.06%-5.14M |
-Interest expense (Financial expense) | 5.24%14.35M | 4.98%10.63M | 5.23%6.96M | 5.80%3.48M | 106.52%13.63M | 1,561.02%10.13M | 1,244.48%6.62M | 1,552.90%3.29M | 777.40%6.6M | 84.90%609.61K |
-Interest Income (Financial expense) | -0.46%-5.04M | -34.66%-4.29M | -78.33%-2.59M | -34.31%-910.53K | -211.90%-5.02M | -184.21%-3.19M | -349.51%-1.45M | -241.42%-677.94K | -94.90%-1.61M | -73.90%-1.12M |
Research and development | 12.55%58.91M | -2.31%42.16M | -7.36%27.49M | -20.08%11.73M | 10.50%52.34M | 18.66%43.16M | 24.64%29.68M | 36.44%14.67M | 27.67%47.37M | 41.94%36.37M |
Credit Impairment Loss | 23.66%-4.5M | 46.35%-4.01M | 33.26%-3.42M | 61.57%1.34M | -51.71%-5.89M | -104.41%-7.48M | -27.50%-5.12M | 488.74%828.81K | -542.12%-3.88M | -98.08%-3.66M |
Asset Impairment Loss | -72.12%-4.69M | 150.09%265.38K | 75.05%-115.47K | -120.92%-369.41K | -46.14%-2.72M | 50.98%-529.82K | 48.51%-462.81K | 29.66%-167.21K | -175.72%-1.86M | -7.77%-1.08M |
Other net revenue | 107.62%7.35M | 490.86%8.46M | 428.46%5.68M | 67.33%5.78M | 1,810.80%3.54M | 35.39%-2.16M | 49.51%-1.73M | 6.05%3.46M | -102.82%-206.86K | -487.60%-3.35M |
Fair value change income | -131.51%-272.17K | -114.73%-144.35K | -555.06%-133.98K | -109.43%-78.35K | 207.89%863.66K | 272.24%979.93K | 101.93%29.44K | 1,877.94%830.67K | -1,056.66%-800.51K | -84.76%-568.93K |
Invest income | 310.13%4.44M | 1,564.86%2.71M | 398.88%1.63M | 367.86%759.54K | 136.06%1.08M | 105.85%162.55K | 131.03%325.96K | -181.96%-283.56K | -254.12%-3M | -270.49%-2.78M |
Asset deal income | -45.38%-321.27K | -45.08%-320.59K | -38.83%-320.59K | ---- | -287.88%-220.98K | -898.60%-220.98K | -8,992.05%-230.93K | -9,145.89%-230.93K | 211.63%117.62K | 67.22%-22.13K |
Other revenue | 21.62%12.68M | 102.16%9.96M | 115.87%8.04M | 66.73%4.13M | 13.00%10.43M | 3.46%4.93M | -8.36%3.73M | -18.99%2.48M | 35.00%9.23M | 93.63%4.76M |
Operating profit | 22.67%117.24M | 20.55%85.12M | 21.51%51.64M | 24.35%24.24M | -9.08%95.58M | -16.94%70.61M | -23.11%42.5M | -34.04%19.49M | -3.26%105.12M | 1.79%85M |
Add:Non operating Income | -65.48%76.05K | -79.22%51.68K | -92.65%8.81K | -66.42%8.8K | -3.41%220.31K | 122.02%248.72K | 391.70%119.87K | 2,757,798.95%26.2K | 1,622.37%228.09K | 745.95%112.03K |
Less:Non operating expense | 56.90%3.69M | 167.16%3.03M | 248.97%2.65M | -76.98%153.31K | 62.59%2.35M | 208.19%1.13M | 389.62%760.8K | 6,208.38%666.1K | 143.56%1.45M | 10.39%367.59K |
Total profit | 21.60%113.63M | 17.81%82.14M | 17.05%48.99M | 27.80%24.09M | -10.07%93.45M | -17.73%69.72M | -24.09%41.86M | -36.18%18.85M | -3.87%103.91M | 1.87%84.75M |
Less:Income tax cost | 54.80%17.39M | 40.44%12.25M | 81.14%7.33M | 24.78%4.24M | -18.40%11.23M | -34.85%8.72M | -43.65%4.05M | -14.67%3.4M | -8.56%13.77M | 12.12%13.39M |
Net profit | 17.06%96.24M | 14.58%69.89M | 10.19%41.66M | 28.46%19.86M | -8.80%82.21M | -14.52%61M | -21.17%37.81M | -39.53%15.46M | -3.11%90.14M | 0.15%71.36M |
Net profit from continuing operation | 17.06%96.24M | 14.58%69.89M | 10.19%41.66M | 28.46%19.86M | -8.80%82.21M | -14.52%61M | -21.17%37.81M | -39.53%15.46M | -3.11%90.14M | 0.15%71.36M |
Net profit of parent company owners | 17.06%96.24M | 14.58%69.89M | 10.19%41.66M | 28.46%19.86M | -8.80%82.21M | -14.52%61M | -21.17%37.81M | -39.53%15.46M | -3.11%90.14M | 0.15%71.36M |
Earning per share | ||||||||||
Basic earning per share | 17.19%0.75 | 14.58%0.55 | 10.00%0.33 | 33.33%0.16 | -9.86%0.64 | -14.29%0.48 | -21.05%0.3 | -40.00%0.12 | -2.74%0.71 | 0.00%0.56 |
Diluted earning per share | 16.18%0.79 | 11.54%0.58 | 6.06%0.35 | 21.43%0.17 | -5.56%0.68 | -7.14%0.52 | -13.16%0.33 | -30.00%0.14 | -1.37%0.72 | 0.00%0.56 |
Other composite income | ||||||||||
Total composite income | 17.06%96.24M | 14.58%69.89M | 10.19%41.66M | 28.46%19.86M | -8.80%82.21M | -14.52%61M | -21.17%37.81M | -39.53%15.46M | -3.11%90.14M | 0.15%71.36M |
Total composite income of parent company owners | 17.06%96.24M | 14.58%69.89M | 10.19%41.66M | 28.46%19.86M | -8.80%82.21M | -14.52%61M | -21.17%37.81M | -39.53%15.46M | -3.11%90.14M | 0.15%71.36M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.